Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration

<table>Column chart showing the change in mean aqueous VEGF levels (a) and change in mean aqueous IL-6 levels (b) in the study patients. The error bar represents standard deviation.</table>

Journal of Ophthalmology

fig1

Figure 1

Figure 1: Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration 

Figure 1 | Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration 